RECOMBITEK Lyme
Targeted protection through recombinant technology.
By using only pure outer surface protein A (OspA), RECOMBITEK Lyme provides efficacy without the potentially harmful flagellan protein.15 Plus, RECOMBITEK Lyme contains no chemical adjuvants, thus reducing the potential risk typically associated with adjuvants.
- Recombinant subunit technology uses only a pure non-adjuvanted protein to stimulate immunity
- In one study, shown to completely block transmission of Lyme disease spirochete18
- Not a whole cell bacteria